zoledronic acid has been researched along with Alveolar Bone Atrophy in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Aung, KT; Dang, AT; Hara, ES; Ishibashi, K; Kuboki, T; Mikai, A; Nawachi, K; Ono, M; Ono-Kimura, A; Oohashi, T; Tanaka, Y; Tosa, I | 1 |
| Helm, A; Rao, NJ; Wang, JY; Yu, RQ; Zheng, LW | 1 |
| Du, Y; Kong, F; Li, J; She, P; Yao, C; Zhang, F; Zhang, Q | 1 |
| Leung, YY; Rao, NJ; Wang, JY; Yu, RQ; Zheng, LW | 1 |
| Deng, C; Liu, J; Luo, N; Mattheos, N; Su, C; Tang, H; Wang, Z | 1 |
| Liu, X; Lu, E; Mao, C; Qin, A; Xu, X; Zhang, X | 1 |
| Chatani, M; Funatsu, T; Isawa, M; Karakawa, A; Kuritani, M; Negishi-Koga, T; Sakai, N; Takami, M | 1 |
| Jurkovic, R; Siebert, T; Statelova, D; Strecha, J | 1 |
| Leung, WK; Li, CL; Lu, WW; Seneviratne, CJ; Zheng, LW; Zwahlen, RA | 1 |
| Huo, L; Li, CL; Lu, WW; Seneviratne, CJ; Zheng, LW | 1 |
| Cardoso, CL; Cavenago, BC; Curi, MM; Curra, C; Ferreira, O; Matsumoto, MA; Santiago, JF; Santos, PL | 1 |
| Gong, X; Sheng, Q; Su, J; Yu, W; Zhao, H | 1 |
| Abati, S; Carmagnola, D; Celestino, S | 1 |
| Buschang, PH; Campbell, PM; Hinton, R; Naidu, A; Ortega, AJ | 1 |
| Fedele, S; Lanza, A; Lo Russo, L; Marenzi, G; Mignogna, MD; Sammartino, G | 1 |
| Braun, E; Iacono, VJ | 1 |
| Dai, RC; Jiang, YB; Liao, EY; Liu, JH; Ma, YL; Sheng, ZF; Xu, K; Zhang, YH | 1 |
17 other study(ies) available for zoledronic acid and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
Topics: Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Transplantation; Calcium Phosphates; Cyclophosphamide; Diphosphonates; Disease Models, Animal; Female; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Recombinant Proteins; Tooth Extraction; Transforming Growth Factor beta; Wound Healing; Zoledronic Acid | 2021 |
Effect of Periapical Diseases in Development of MRONJ in Immunocompromised Mouse Model.
Topics: Alveolar Bone Loss; Animals; Bone Density; Bone Density Conservation Agents; Dexamethasone; Disease Models, Animal; Female; Mandible; Mice; Mice, Inbred C57BL; Molar; Osteonecrosis; Ovariectomy; Periapical Diseases; X-Ray Microtomography; Zoledronic Acid | 2019 |
Implantable zoledronate-PLGA microcapsules ameliorate alveolar bone loss, gingival inflammation and oxidative stress in an experimental periodontitis rat model.
Topics: Alveolar Bone Loss; Animals; Antioxidants; Capsules; Catalase; Cytokines; Disease Models, Animal; Gingiva; Humans; Inflammation; Osteoprotegerin; Oxidative Stress; Polylactic Acid-Polyglycolic Acid Copolymer; Prosthesis Implantation; Rats; Superoxide Dismutase; Zoledronic Acid | 2021 |
Role of Periapical Diseases in Medication-Related Osteonecrosis of the Jaws.
Topics: Alveolar Bone Loss; Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Humans; Imidazoles; Jaw; Mandible; Mice; Molar; Necrosis; Osteocytes; Osteonecrosis; Periapical Diseases; Tomography, X-Ray Computed; Zoledronic Acid | 2017 |
The effects of icariin on wound healing of extraction sites with administration of zoledronic and dexamethasone: A rat model study.
Topics: Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Collagen Type I; Dexamethasone; Diphosphonates; Female; Flavonoids; Imidazoles; Immunohistochemistry; Mandible; Models, Animal; Molar; Osteocalcin; Osteoclasts; Rats; Tartrate-Resistant Acid Phosphatase; Tooth Extraction; Vascular Endothelial Growth Factor A; Wound Healing; Zoledronic Acid | 2018 |
Bis‑enoxacin blocks alveolar bone resorption in rats with ovariectomy‑induced osteoporosis.
Topics: Alveolar Bone Loss; Animals; Body Weight; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Enoxacin; Female; Imidazoles; Microscopy, Fluorescence; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; X-Ray Microtomography; Zoledronic Acid | 2018 |
Anti-mouse RANKL Antibodies Inhibit Alveolar Bone Destruction in Periodontitis Model Mice.
Topics: Alveolar Bone Loss; Animals; Antibodies; Diphosphonates; Disease Models, Animal; Imidazoles; Lipopolysaccharides; Male; Mice, Inbred C57BL; Osteoclasts; Periodontitis; RANK Ligand; Skull; Zoledronic Acid | 2018 |
Immediate Implant Placement in a Patient With Osteoporosis Undergoing Bisphosphonate Therapy: 1-Year Preliminary Prospective Study.
Topics: Alveolar Bone Loss; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Dental Implantation, Endosseous; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Jaw, Edentulous, Partially; Mandible; Middle Aged; Osseointegration; Osteoporosis, Postmenopausal; Prospective Studies; Risk Factors; Survival Analysis; Tooth Extraction; Tooth Socket; Zoledronic Acid | 2015 |
Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats.
Topics: Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Disease Models, Animal; Disease Progression; Female; Imidazoles; Ovariectomy; Periodontal Diseases; Random Allocation; Rats; Rats, Sprague-Dawley; X-Ray Microtomography; Zoledronic Acid | 2016 |
Impact of Actinomyces naeslundii on bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats with periodontitis.
Topics: Actinomyces; Actinomycosis; Alveolar Bone Loss; Animals; Bacterial Load; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density; Bone Density Conservation Agents; Cancellous Bone; Diphosphonates; Disease Models, Animal; Disease Progression; Female; Imidazoles; Mandibular Diseases; Ovariectomy; Periodontitis; Random Allocation; Rats; Rats, Sprague-Dawley; X-Ray Microtomography; Zoledronic Acid | 2015 |
Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model.
Topics: Administration, Intravenous; Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Imidazoles; Incisor; Male; Maxillary Diseases; Models, Animal; Osteitis; Osteolysis; Rats, Wistar; Tooth Extraction; X-Ray Microtomography; Zoledronic Acid | 2016 |
Skeletal Site-specific Effects of Zoledronate on in vivo Bone Remodeling and in vitro BMSCs Osteogenic Activity.
Topics: Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Remodeling; Cell Proliferation; Cells, Cultured; Diphosphonates; Disease Models, Animal; Female; Gene Expression Regulation; Humans; Imidazoles; Maxilla; Mesenchymal Stem Cells; Osteoprotegerin; RANK Ligand; Rats; Rats, Sprague-Dawley; Wnt3A Protein; Zoledronic Acid | 2017 |
Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
Topics: Aged; Aged, 80 and over; Alveolar Bone Loss; Antineoplastic Agents; Bone Density Conservation Agents; Diphosphonates; DMF Index; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Neoplasms; Osteonecrosis; Periodontal Index; Pilot Projects; Retrospective Studies; Risk Factors; Stomatitis, Denture; Tooth Extraction; Zoledronic Acid | 2008 |
Local application of zoledronate for maximum anchorage during space closure.
Topics: Administration, Topical; Alveolar Bone Loss; Animals; Bone Density Conservation Agents; Diphosphonates; Imidazoles; Orthodontic Anchorage Procedures; Orthodontic Space Closure; Rats; Zoledronic Acid | 2012 |
Gorham's disease of the mandible mimicking periodontal disease on radiograph.
Topics: Adult; Alveolar Bone Loss; Diagnosis, Differential; Diphosphonates; Female; Humans; Imidazoles; Mandibular Diseases; Osteolysis, Essential; Tomography, X-Ray Computed; Zoledronic Acid | 2005 |
Bisphosphonates: case report of nonsurgical periodontal therapy and osteochemonecrosis.
Topics: Alveolar Bone Loss; Bone Density Conservation Agents; Dental Scaling; Diphosphonates; Humans; Imidazoles; Male; Mandibular Diseases; Middle Aged; Oral Fistula; Osteonecrosis; Periodontitis; Root Planing; Tooth Extraction; Tooth Socket; Zoledronic Acid | 2006 |
Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
Topics: Acid Phosphatase; Alkaline Phosphatase; Alveolar Bone Loss; Animals; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Imidazoles; Isoenzymes; Mandible; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoprotegerin; Random Allocation; Tartrate-Resistant Acid Phosphatase; Tibia; Zoledronic Acid | 2009 |